LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 1389 | 553 | 5740 | 0.0963 | -0.3623 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 1389 | 376 | 5147 | 0.0731 | -0.4992 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 1389 | 452 | 5447 | 0.0830 | -0.4342 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1389 | 506 | 5740 | 0.0881 | -0.3894 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1389 | 4907 | 5147 | 0.9534 | 0.9501 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1389 | 4573 | 5447 | 0.8394 | 0.8301 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1389 | 4145 | 5740 | 0.7221 | 0.7059 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1389 | 5180 | 5147 | 1.0064 | 1.0068 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1389 | 5068 | 5447 | 0.9303 | 0.9280 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1389 | 4241 | 5740 | 0.7388 | 0.7251 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1389 | 4954 | 5147 | 0.9625 | 0.9599 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1389 | 4643 | 5447 | 0.8523 | 0.8442 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1389 | 5204 | 5740 | 0.9065 | 0.9064 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1389 | 4845 | 5147 | 0.9413 | 0.9370 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1389 | 4254 | 5447 | 0.7809 | 0.7642 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1389 | 4840 | 5740 | 0.8431 | 0.8401 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1389 | 3547 | 5147 | 0.6891 | 0.6423 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1389 | 3883 | 5447 | 0.7128 | 0.6844 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1389 | 3847 | 5740 | 0.6702 | 0.6448 |
MCF7 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1389 | 624 | 5147 | 0.1212 | -0.3452 |
MCF7 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1389 | 720 | 5447 | 0.1322 | -0.2834 |
MCF7 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1389 | 938 | 5740 | 0.1634 | -0.1745 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1389 | 3645 | 5147 | 0.7082 | 0.6662 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1389 | 3799 | 5447 | 0.6973 | 0.6658 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1389 | 3501 | 5740 | 0.6099 | 0.5708 |